Inovio’s INO-3112 Shows Robust Immune Responses in Patients With Head & Neck Cancer
Go back to Inovio’s INO-3112 Shows Robust Immune Responses in Patients With Head & Neck Cancer| INOVIO PHARMACEUTICALS, Inc. (NASDAQ: INO) | Delayed: 1.13 +0.04 (3.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.09 | 52 Week High | $11.69 | |||
| Open | $1.07 | 52 Week Low | $4.50 | |||
| Day High | $1.15 | P/E | N/A | |||
| Day Low | $1.04 | EPS | $-0.28 | |||
| Volume | 3,973,586 | |||||
